Patexia Logo
Patexia Logo
Products
  • IP Intelligence Reports
  • Patexia Concierge
  • Patent Analyzer
  • Trademarks Analyzer
  • Litigation Analyzer
  • All Products
Services
  • Lateral Opportunities
  • Expert Witness
  • Research Studies
  • Strategic Partnership
  • All Services
IP Community
  • IP Community
  • IP Webinars
  • In the News
Company
  • About Us
  • Press Release
  • Careers
  • Contact Us
Login
JoinBook a Meeting
Company
  • About Us
  • Press Release
  • Careers
  • Contact Us
Products
  • IP Intelligence Reports
  • Patexia Concierge
  • Patent Analyzer
  • Trademarks Analyzer
  • Litigation Analyzer
Services
  • Lateral Opportunities
  • Expert Witness
  • Research Studies
  • Strategic Partnership
Resources
  • IP Community
  • IP Webinars
  • In the News
  • Help Center
Contact
  • (310) 909-7611
  • 100 Wilshire Blvd. Suite 700
    Santa Monica, CA 90401 USA
  • info@patexia.com
  • Contact Us
Follow Us
© 2025
100 Wilshire Blvd, Suite 700, Santa Monica, CA 90401 USA
Terms and Conditions|Privacy Policy
Back to All Articles
Browse articles with tag: Novartis
You must be logged in to create a new article
All Articles
Bryan Wheelock
Apr 19, 2017
•
Featured
Just Because the Board Didn’t Say It, Doesn’t Mean that the Board Didn’t Think It
In Novartis AG v. Torrent Pharmaceuticals Limited, [2016-1352] (April 12, 2017), the Federal Circuit affirmed the PTAB’s determination that the... Read More
Valerie Clark
Apr 27, 2012
•
Featured
What one drug company is doing to increase health care costs
International pharmaceutical giant Novartis is suing the United Kingdom's national health system (NHS) for using a cheaper, unlicensed drug instead... Read More
Alejandro Freixes
Nov 1, 2011
ADHD drugs do not increase heart problems in kids
CHICAGO (Reuters) - Stimulants used to treat attention deficit hyperactivity disorder do not increase the risk of heart attacks, strokes... Read More
Alejandro Freixes
Oct 26, 2011
Biogen MS drug BG-12 meets goal of second trial
  By Toni Clarke               (Reuters) - Biogen Idec Inc's said on Wednesday its... Read More
Alejandro Freixes
Oct 26, 2011
World Intellectual Property Organization holds an innovation consortium
  GENEVA (Reuters) - The World Intellectual Property Organization launched a consortium on Wednesday that would allow the public and... Read More
Alejandro Freixes
Oct 25, 2011
Novartis, Vectura lung drugs face delay in U.S.
  LONDON (Reuters) - Two lung drugs being developed by Novartis and its British partner Vectura face delays in the United States, the Swiss... Read More
Patexia Insight 237: Where Are They Now? Tracking 2024’s Top ITC Attorney Moves and Rising Firms
Pedram Sameni
Apr 17, 2025
•
ITC Litigation
Lateral Moves
Patexia Insight 237: Where Are They Now? Tracking 2024’s Top ITC Attorney Moves and Rising Firms
As Section 337 investigations at the International Trade Commission (ITC) remain a key strategy for companies seeking swift and effective... Read More
Patexia Insight 238: Trademark Filings Increase as China Leads Foreign Applicants
Pedram Sameni
12 hours ago
•
Trademark Prosecution
Patexia Insight 238: Trademark Filings Increase as China Leads Foreign Applicants
According to Patexia’s latest Trademark Intelligence Report, scheduled for release tomorrow, trademark application activity at the United States Patent and... Read More
Patexia Insight 237: Where Are They Now? Tracking 2024’s Top ITC Attorney Moves and Rising Firms
Pedram Sameni
Apr 17, 2025
•
ITC Litigation
Lateral Moves
Patexia Insight 237: Where Are They Now? Tracking 2024’s Top ITC Attorney Moves and Rising Firms
As Section 337 investigations at the International Trade Commission (ITC) remain a key strategy for companies seeking swift and effective... Read More
Patexia Insight 238: Trademark Filings Increase as China Leads Foreign Applicants
Pedram Sameni
12 hours ago
•
Trademark Prosecution
Patexia Insight 238: Trademark Filings Increase as China Leads Foreign Applicants
According to Patexia’s latest Trademark Intelligence Report, scheduled for release tomorrow, trademark application activity at the United States Patent and... Read More
Patexia Insight 237: Where Are They Now? Tracking 2024’s Top ITC Attorney Moves and Rising Firms
Pedram Sameni
Apr 17, 2025
•
ITC Litigation
Lateral Moves
Patexia Insight 237: Where Are They Now? Tracking 2024’s Top ITC Attorney Moves and Rising Firms
As Section 337 investigations at the International Trade Commission (ITC) remain a key strategy for companies seeking swift and effective... Read More
Featured